Literature DB >> 28724115

The Efficacy of a Gain-Switched 311-nm Titanium:Sapphire Laser in the Treatment of Vitiligo: A Pilot Study of 14 Patients.

Jung Min Bae1, Ji Hae Lee1, Yu Seok Jung1, Gyong Moon Kim1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28724115      PMCID： PMC5817588          DOI： 10.1001/jamadermatol.2017.2175

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  6 in total

1.  Repigmentation of localized vitiligo with the xenon chloride laser.

Authors:  E Baltás; P Nagy; B Bónis; Z Novák; F Ignácz; G Szabó; Z Bor; A Dobozy; L Kemény
Journal:  Br J Dermatol       Date:  2001-06       Impact factor: 9.302

Review 2.  Ultraviolet-based therapy for vitiligo: what's new?

Authors:  Iltefat H Hamzavi; Henry W Lim; Zain U Syed
Journal:  Indian J Dermatol Venereol Leprol       Date:  2012 Jan-Feb       Impact factor: 2.545

3.  Clinical efficacy of a 308 nm excimer laser in the treatment of vitiligo.

Authors:  Xiu-Ying Zhang; Yan-Ling He; Jie Dong; Jun-Zhu Xu; Jie Wang
Journal:  Photodermatol Photoimmunol Photomed       Date:  2010-06       Impact factor: 3.135

4.  Gain-switched 311-nm Ti:Sapphire laser might be a potential treatment modality for atopic dermatitis.

Authors:  Sun Young Choi; Chang Taek Oh; Tae-Rin Kwon; Hyun Jung Kwon; Eun Ja Choi; Yu-Jin Jang; Hye Sung Kim; Hong Chu; Seog Kyun Mun; Myeung Nam Kim; Beom Joon Kim
Journal:  Lasers Med Sci       Date:  2016-07-09       Impact factor: 3.161

5.  Association of Quality of Life and Location of Lesions in Patients With Vitiligo.

Authors:  Stephanie Florez-Pollack; Gaoxiang Jia; Lucio Zapata; Clifford Rodgers; Katia Hernandez; Linda S Hynan; Amit G Pandya
Journal:  JAMA Dermatol       Date:  2017-03-01       Impact factor: 10.282

6.  Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.

Authors:  Sami Sasi Yones; Roy A Palmer; Trish M Garibaldinos; John L M Hawk
Journal:  Arch Dermatol       Date:  2007-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.